Hiromasa Kato

Ebara, 1428501, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Organ Crosstalk in CKD-Associated Frailty: Mechanistic Insights, Translational Opportunities, and Clinical Implications.

Organ Crosstalk in CKD-Associated Frailty: Mechanistic Insights, Translational Opportunities, and Clinical Implications.

Journal: Biological & pharmaceutical bulletin
Published: May 31, 2026

Protective Effects of the Phytocannabinoid Cannabidiol on Disuse-Induced Muscle Atrophy through Modulation of Proteolysis and Mitochondrial Regulation.

Protective Effects of the Phytocannabinoid Cannabidiol on Disuse-Induced Muscle Atrophy through Modulation of Proteolysis and Mitochondrial Regulation.

Journal: Biological & pharmaceutical bulletin
Published: May 20, 2026

Developmental expression of azathioprine-metabolizing enzymes in mice liver and its implication for fetal drug toxicity.

Developmental expression of azathioprine-metabolizing enzymes in mice liver and its implication for fetal drug toxicity.

Journal: Biochemical and biophysical research communications
Published: February 21, 2026

Quantitative analysis of Cyp1a2 expression and temporal characterization of zonation structure formation during mouse liver development.

Quantitative analysis of Cyp1a2 expression and temporal characterization of zonation structure formation during mouse liver development.

Journal: The Journal of toxicological sciences
Published: November 30, 2025

Liquid chromatography-mass spectrometry-based characterization of maternal-fetal pharmacokinetics of diazepam and its metabolites in pregnant mice.

Liquid chromatography-mass spectrometry-based characterization of maternal-fetal pharmacokinetics of diazepam and its metabolites in pregnant mice.

Journal: British journal of pharmacology
Published: April 15, 2025

Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment.

Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment.

Journal: Free radical biology & medicine
Published: March 04, 2024

Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation.

Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation.

Journal: Toxins
Published: February 06, 2023

Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway.

Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway.

Journal: Journal of cachexia, sarcopenia and muscle
Published: March 01, 2021

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.

Journal: Diabetes care
Published: December 11, 2020

Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis.

Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis.

Journal: Biological & pharmaceutical bulletin
Published: October 01, 2020

Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase.

Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase.

Journal: Toxins
Published: June 10, 2020

Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids.

Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids.

Journal: Kidney360
Published: November 26, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026